Arcadia Historical Income Statement
| RKDA Stock | USD 2.74 0.15 5.79% |
Historical analysis of Arcadia Biosciences income statement accounts such as Gross Profit of 2.1 M, Other Operating Expenses of 24.9 M, Research Development of 1.3 M or Cost Of Revenue of 3.1 M can show how well Arcadia Biosciences performed in making a profits. Evaluating Arcadia Biosciences income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Arcadia Biosciences's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Arcadia Biosciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Arcadia Biosciences is a good buy for the upcoming year.
Arcadia |
About Arcadia Income Statement Analysis
Arcadia Biosciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Arcadia Biosciences shareholders. The income statement also shows Arcadia investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Arcadia Biosciences Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Arcadia Biosciences generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Arcadia Biosciences. It is also known as Arcadia Biosciences overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Most accounts from Arcadia Biosciences' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Arcadia Biosciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcadia Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.At present, Arcadia Biosciences' Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Total Revenue is expected to grow to about 6 M, whereas Interest Expense is forecasted to decline to about 247.1 K.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 26.8M | 19.6M | 16.0M | 21.7M | Cost Of Revenue | 8.7M | 9.8M | 3.3M | 3.1M |
Arcadia Biosciences income statement Correlations
Click cells to compare fundamentals
Arcadia Biosciences Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Arcadia Biosciences income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | (48K) | 662K | 1.0M | 1.4M | 287K | 501.1K | |
| Interest Expense | 5K | 47K | 20K | 289K | 260.1K | 247.1K | |
| Selling General Administrative | 13.6M | 16.5M | 22.9M | 18.0M | 17.7M | 14.7M | |
| Total Revenue | 1.2M | 8.0M | 6.8M | 10.0M | 5.3M | 6.0M | |
| Gross Profit | 284K | 2.8M | (1.9M) | 154K | 2.0M | 2.1M | |
| Other Operating Expenses | 21.6M | 29.6M | 35.5M | 29.4M | 19.3M | 24.9M | |
| Operating Income | (20.4M) | (21.6M) | (35.5M) | (19.4M) | (13.9M) | (14.6M) | |
| Ebit | (20.4M) | (6.1M) | (24.3M) | (15.0M) | (14.2M) | (14.9M) | |
| Research Development | 7.1M | 8.0M | 3.9M | 1.5M | 1.4M | 1.3M | |
| Ebitda | (20.4M) | (5.4M) | (23.3M) | (13.6M) | (13.9M) | (14.6M) | |
| Cost Of Revenue | 885K | 5.2M | 8.7M | 9.8M | 3.3M | 3.1M | |
| Total Operating Expenses | 20.7M | 24.4M | 26.8M | 19.6M | 16.0M | 21.7M | |
| Income Before Tax | (28.9M) | (6.2M) | (16.1M) | (15.6M) | (13.2M) | (13.8M) | |
| Total Other Income Expense Net | (8.5M) | 6.6M | 19.4M | 3.2M | 781K | 742.0K | |
| Net Income | (28.9M) | (6.0M) | (16.1M) | (15.6M) | (14.0M) | (14.7M) | |
| Income Tax Expense | 10K | 2K | (124K) | 14K | 8K | 7.6K | |
| Net Income From Continuing Ops | (28.2M) | (6.0M) | (16.1M) | (15.6M) | (18.5M) | (19.4M) | |
| Net Income Applicable To Common Shares | (13.5M) | (28.8M) | (4.7M) | (14.7M) | (16.9M) | (17.7M) | |
| Tax Provision | 10K | 2K | (124K) | 14K | 12.6K | 13.2K | |
| Non Operating Income Net Other | (619K) | 10.0M | (8.8M) | 6.7M | 7.7M | 8.1M | |
| Net Interest Income | (5K) | (47K) | (789K) | 289K | 704K | 739.2K | |
| Minority Interest | (68K) | 827K | 1.5M | 236K | 89K | 84.6K | |
| Reconciled Depreciation | 194K | 662K | 1.0M | 479K | 313K | 491.2K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Arcadia Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arcadia Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arcadia Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arcadia Biosciences Stock:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Arcadia Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. For information on how to trade Arcadia Stock refer to our How to Trade Arcadia Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Agricultural Products & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcadia Biosciences. If investors know Arcadia will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcadia Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.285 | Earnings Share (6.77) | Revenue Per Share 3.802 | Quarterly Revenue Growth (0.04) | Return On Assets (0.39) |
The market value of Arcadia Biosciences is measured differently than its book value, which is the value of Arcadia that is recorded on the company's balance sheet. Investors also form their own opinion of Arcadia Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcadia Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcadia Biosciences' market value can be influenced by many factors that don't directly affect Arcadia Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcadia Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcadia Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcadia Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.